Strategies to enhance VEGFR-3/VEGF-C signaling could improve outcomes in neurodegenerative diseases, multiple sclerosis, and brain injuries, with ongoing research exploring molecular mechanisms, therapeutic interventions, and advanced imaging for real-time monitoring [41,47]. The gene discussed is FLT4; the disease is neurodegenerative disease.